Home page

News:

Announcements

Find out about all of the free NHS services available to support you as you go try to give up smoking.

Stay safe in the sun, including sunscreens, sunburn relief, heat exhaustion, eczema and moles. Summer holidays are great fun for children, but can bring risks. Find out more

01 Jul - 01 Oct
Change for Life

Would you like loads of tips and help to make changes for a healthier future? As part of Change4Life, you will receive tons of helpful information, recipes, tools, tips, and games for the kids.

Yahoo Health

Can home cooking be hazardous to your health? (AP)

AP - Could your kitchen at home pass a restaurant inspection?

Botox maker to pay $600M to resolve investigation (AP)

Food and Drug Administration (FDA) Commissioner Margaret Hamburg speaks to reporters during a news conference at the Justice Department in Washington, Wednesday, Sep. 1, 2010, regarding a major settlement with a pharmaceutical company for False Claims Act and off-label marketing violations. Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a years long federal investigation into its marketing of the top-selling, botulin-based drug. (AP Photo/Manuel Balce Ceneta)

AP - Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug.

New test seen as big advance in diagnosing TB (AP)

This undated photo released by Cepheid, shows a Cepheid Xpert MTB/RIF cartridge. The cartridge is part of a test that is a major advance in diagnosing tuberculosis and can reveal in less than two hours, with very high accuracy, whether someone has the disease and if it's resistant to the main drug for treating it. (AP Photo/Cepheid) NO SALES

AP - Scientists are reporting a major advance in diagnosing tuberculosis: A new test can reveal in less than two hours, with very high accuracy, whether someone has the disease and if it's resistant to the main drug for treating it.

Journal editors question sale of diet pill Meridia (AP)

AP - Editors of a top medical journal call Meridia "another flawed diet pill" and question whether it should stay on the market as a study shows it raises the risk of heart attack and stroke in people with heart problems.

Benefits seen for high-risk women in ovary removal (AP)

AP - Surgery to remove healthy ovaries gives a triple benefit to high-risk women: It lowers their threat of breast and ovarian cancer, and boosts their chances of living longer, new research suggests.

Double hand transplant patient shows new hands (AP)

Dr. Richard Edwards scratches his face with one of his new hands during a news conference at Jewish Hospital, in Louisville Thursday, Sept. 2, 2010. The 55-year-old chiropractor from Edmond, Okla., had his hands severely burned in a fire in 2006. Edwards says he can wiggle fingers on both his new hands. He was the nation's third double hand transplant recipient. (AP Photo/The Courier Journal, Michael Hayman) No sales No mags No archives

AP - The recipient of a rare double hand transplant says he feels "fantastic" and can wiggle fingers on both his new hands.

Study: Diet Drug Meridia May Boost Heart Risks (Time.com)

Time.com - A new study finds that some users of the weight-loss pill Meridia may have an increased risk of heart attack or stroke

For Bonobo Males, Mom Is the Best Wingman (LiveScience.com)

LiveScience.com - To most human males, the thought of your mother anywhere near your sex life is probably horrifying. Not so for the bonobo, one of our closest primate relatives. A new study confirms that hanging out with mom boosts male bonobos' chances of getting intimate with a fertile female.

Clinical Trials Update: Sept. 3, 2010 (HealthDay)

HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

U.S. medical programs missing millions of kids: report (Reuters)

Reuters - An estimated five million uninsured children in the United States were eligible for Medicaid or the Childrens Health Insurance Program (CHIP) but were not enrolled in either plan, according to a new report.

MedPage Today

Metformin Shows Anticancer Potential (CME/CE)

(MedPage Today) -- Nondiabetic patients with precancerous rectal lesions had significant histologic improvement after one month of treatment with metformin, data from a small randomized clinical trial showed.

Bisphosphonates Tied to Esophageal Cancer (CME/CE)

(MedPage Today) -- A second look at British registry data indicates that esophageal cancer may be more common after all in patients taking oral bisphosphonate drugs for long periods.

Age No Barrier to Oral Anticoagulants (CME/CE)

(MedPage Today) -- Age alone shouldn't deter appropriate oral anticoagulant use in elderly atrial fibrillation patients, according to a review.

For Resistant Asthma, First Check the Basics (CME/CE)

(MedPage Today) -- At least half of children with severe, apparently treatment-resistant asthma can be successfully managed with conventional treatments using a thorough, multidisciplinary approach, researchers suggested.

ESC: In CABG, Two Grafts as Safe as One (CME/CE)

STOCKHOLM (MedPage Today) -- Using two internal mammary arteries instead of one for CABG does not increase mortality, MI, stroke, or revascularization, one-year results of the multicenter randomized Arterial Revascularization Trial (ART) showed.

More Americans Taking Rx Drugs (CME/CE)

(MedPage Today) -- Nearly half of all Americans -- 48% -- took at least one prescription drug in a one-month period in 2007-2008, a four percentage point hike over a decade, researchers found.

Growth of Employer Plans Foreseen With Health Reform

WASHINGTON (MedPage Today) -- Employer-sponsored insurance will not only remain a cornerstone of the American healthcare system, but it will increase in prevalence in the post-healthcare reform environment, according to several researchers.

Rapid TB Test Shows High Accuracy (CME/CE)

(MedPage Today) -- A two-hour molecular diagnostic test detected tuberculosis bacteria, including rifampin-resistant strains, with sensitivity and specificity well over 90%, researchers found.

Attitudes More than Growth Response Drive Growth Hormone Therapy (CME/CE)

(MedPage Today) -- While a physician's decision to start a child on growth hormone is usually consistent with evidence-based guidelines, continuation or intensification of therapy is strongly influenced by factors other than treatment response, according to a new survey.

ESC: Novel Agent Blocks Hyperkalemia in Heart Failure (CME/CE)

STOCKHOLM (MedPage Today) -- An investigational potassium binder prevented hyperkalemia in at-risk patients with heart failure, a randomized, placebo-controlled trial showed.

WHO Swine Flu

Influenza - update 115

Worldwide, H1N1 2009 virus transmission remains most intense in parts of India and in parts of the temperate southern hemisphere, particularly New Zealand and more recently in Australia.

Influenza - update 114

The situation in New Zealand and India remains largely unchanged since the last update. Influenza H1N1 (2009) virus transmission remains locally intense in parts of India and New Zealand.

Influenza - update 113

Influenza H1N1 (2009) virus transmission remains locally intense in parts of India and New Zealand.

Director-General statement following the ninth meeting of the Emergency Committee

The Emergency Committee held its ninth meeting by teleconference on 10 August 2010.

WHO recommendations for the post-pandemic period

The world is now in the post-pandemic period. Based on knowledge about past pandemics, the H1N1 (2009) virus is expected to continue to circulate as a seasonal virus for some years to come. While the level of concern is now greatly diminished, vigilance on the part of national health authorities remains important. Such vigilance is especially critical in the immediate post-pandemic period, when the behaviour of the H1N1 (2009) virus as a seasonal virus cannot be reliably predicted.

Pandemic (H1N1) 2009 - update 112

As of 1 August 2010, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18449 deaths.

Pandemic (H1N1) 2009 - update 111

As of 25 July 2010, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18398 deaths.

Pandemic (H1N1) 2009 - update 110

As of 18 July 2010, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18366 deaths.

Monitoring patterns and levels of worldwide activity

As part of regular monitoring of H1N1 pandemic influenza, the WHO is in close dialogue with public health experts in countries worldwide, specifically to determine whether H1N1 activity has returned to levels and patterns normally seen for seasonal flu.

Pandemic (H1N1) 2009 - update 109

As of 12 July, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18337deaths.

Announcements

Yahoo Health

MedPage Today

WHO Swine Flu

Welcome to South Milford Surgery Online

Opening Hours

Practice Information